[HTML][HTML] Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review

AL Depla, CH Scharloo-Karels, MAA De Jong… - European Journal of …, 2014 - Elsevier
Background Radiation-associated angiosarcoma (RAAS) of the breast is a rare, aggressive
disease. The incidence is increasing with the prolonged survival of women irradiated for …

Radiation-induced sarcoma of the breast: a systematic review

GR Sheth, LD Cranmer, BD Smith… - The …, 2012 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Evaluate the level of evidence to inform decision making for the treatment radiation induced …

Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer

KE Torres, V Ravi, K Kin, M Yi, BA Guadagnolo… - Annals of surgical …, 2013 - Springer
Background Radiation-associated angiosarcoma (RAAS) is a devastating disease
occasionally observed in breast cancer patients treated with radiation. Due to its rarity, our …

Angiosarcoma of the breast

KN Glazebrook, MJ Magut… - American Journal of …, 2008 - Am Roentgen Ray Soc
OBJECTIVE. This article describes the imaging findings, pathologic correlation, and clinical
presentation of rare primary and secondary angiosarcomas of the breast. CONCLUSION …

Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience

JS Scow, CA Reynolds, AC Degnim… - Journal of surgical …, 2010 - Wiley Online Library
Abstract Background and Objectives Angiosarcoma of the breast can be divided into primary
and secondary. The objective was to determine clinicopathologic factors associated with …

Angiosarcoma: state of the art and perspectives

N Penel, S Marréaud, YM Robin… - Critical reviews in …, 2011 - Elsevier
We propose a literature review of available data on angiosarcoma (AS). AS account for 1%
of adult soft tissue sarcoma. Two risk factors are well-establish chronic lymhoedema …

Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients

T Nagano, Y Yamada, T Ikeda, H Kanki… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. Effective treatment options are limited for patients with cutaneous
angiosarcoma (AS). Docetaxel, a member of the taxane family of drugs, reportedly has been …

[HTML][HTML] Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma

HR Kim, SY Rha, SH Cheon, JK Roh, YN Park… - Annals of oncology, 2009 - Elsevier
Background Primary hepatic angiosarcoma is a very rare malignancy with a poor prognosis.
While surgical resection has been validated as curative choice, most cases are diagnosed …

[HTML][HTML] Breast sarcomas: current and future perspectives

IA Voutsadakis, K Zaman, S Leyvraz - The Breast, 2011 - Elsevier
Breast sarcomas are rare neoplasms of the breast that need to be clearly distinguished from
the very common breast carcinomas and treated in a multidisciplinary manner modelled …

Reirradiation and hyperthermia for radiation‐associated sarcoma

MAA de Jong, S Oldenborg, S Bing Oei, V Griesdoorn… - Cancer, 2012 - Wiley Online Library
BACKGROUND: The objective of this study was to evaluate the role of reirradiation and
hyperthermia in the treatment of radiation‐associated sarcoma (RAS) in the thoracic region …